Patent 11000489 was granted and assigned to Bryn Pharma, LLC on May, 2021 by the United States Patent and Trademark Office.
Provided herein are epinephrine spray formulations. Also provided herein are methods of treating anaphylaxis by administering epinephrine spray formulations to subjects in need of such treatment.